Accuracy of core biopsy image-guided post-neoadjuvant chemotherapy breast to predict pathologic complete response

• Main Authors: P. V. Krivorotko (Author), V. V. Mortada (Author), R. S. Pesotskiy (Author), A. S. Artemyeva (Author), A. S. Emelyanov (Author), S. S. Ereshchenko (Author), G. A. Dashyan (Author), N. S. Amirov (Author), T. T. Tabagua (Author), L. P. Gigolaeva (Author), A. V. Komyakhov (Author), K. S. Nikolaev (Author), M. M. Mortada (Author), K. Yu. Zernov (Author), E. K. Zhiltsova (Author), V. O. Smirnova (Author), Ya. I. Bondarchuk (Author), D. A. Enaldieva (Author), S. N. Novikov (Author), E. A. Busko (Author), A. V. Chernaya (Author), P. I. Krzhivitskiy (Author), R. M. Paltuev (Author), T. Yu. Semiglazova (Author), V. F. Semiglazov (Author), A. M. Belyaev (Author)
• Format: Book
• Published: ABV-press, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background. Achieving a pathologic complete response (pCR) after neoadjuvant systemic therapy (NST) is a predictive factor for improving disease free and overall survival. In triple negative (TN) and HER2-positive breast cancer (BC), the pCR rate exceeds 60 %. Patients with TN and HER2-positive BC w...